These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10319991)

  • 1. Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model.
    Jones JM; Cui XS; Medina D; Donehower LA
    Cell Growth Differ; 1999 Apr; 10(4):213-22. PubMed ID: 10319991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21.
    Shibata MA; Yoshidome K; Shibata E; Jorcyk CL; Green JE
    Cancer Gene Ther; 2001 Jan; 8(1):23-35. PubMed ID: 11219490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells.
    Liberto M; Cobrinik D; Minden A
    Oncogene; 2002 Feb; 21(10):1590-9. PubMed ID: 11896588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM
    Oncogene; 2000 Nov; 19(47):5338-47. PubMed ID: 11103935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
    Yang WC; Mathew J; Velcich A; Edelmann W; Kucherlapati R; Lipkin M; Yang K; Augenlicht LH
    Cancer Res; 2001 Jan; 61(2):565-9. PubMed ID: 11212250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
    Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T; Varmus HE; Donehower LA
    Cell Growth Differ; 1997 Aug; 8(8):829-38. PubMed ID: 9269892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
    Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
    Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
    Cui XS; Donehower LA
    Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.